TerminatedNot Applicable

Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Stopped: funding freeze

Germany1 participantsStarted 2025-03-01

Plain-language summary

Clinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Min Age 18 years * Acceptance of the organ using the XPS™ ex vivo lung perfusion system is made by the center based on clinical assessment and visual inspection Exclusion Criteria: * The usual criteria for the assessment of donors apply * The transplanting surgeon is not satisfied with the lung assessment on the XPS™ according to clinical criteria

What they're measuring

Survival of patients 1 year after transplantation

Timeframe: 1 year after transplantation

Trial details

NCT IDNCT06795516

SponsorHannover Medical School

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-03

View on ClinicalTrials.gov More Lung Transplantation trials